Home › Urogenital Cancer › Missouri › St. Louis
Urogenital Cancer clinical trials in St. Louis, MO
3 studies for Urogenital Cancer are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
RecruitingObservational studyHealthy volunteers welcome
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- and 5 more
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
RecruitingObservational studyHealthy volunteers welcome
- Washington University School of Medicine, St Louis
Urogenital Cancer trials in other cities
- Washington, DC6 studies
- Houston, TX6 studies
- Columbus, OH5 studies
- Nashville, TN5 studies
- Durham, NC4 studies
- Atlanta, GA3 studies
- Ann Arbor, MI3 studies
- Cedar Rapids, IA3 studies
- Orange, CA3 studies
- Los Angeles, CA3 studies
- Omaha, NE3 studies
- Boston, MA3 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Cancer (all types)46 studies
- Prostate Cancer46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.